Chengfu Yuan

3.6k citations
114 papers · 2.3k indexed · 1 hit paper · h-index 22

Chengfu Yuan

103 papers receiving 2.3k citations

Hit Papers

Breast cancer development and progression: Risk factors, ...9362018202620202023250500750

Peers

Chengfu Yuan
Comparison fields: 5 of 138
  • Cancer Research 778
  • Molecular Biology 1.3k
  • Oncology 457
  • Molecular Medicine 65
  • Biochemistry 67
Replace Changgang Sun with:
Changgang Sun China
Wenshu Chen China
Yue Chen China
Xiaoli Li China
Zhe Wang China
Xiaona Liu China
Jong Kyu Woo South Korea
Larisa Nonn United States
Chih‐Pin Chuu Taiwan
Ming‐Ju Hsieh Taiwan
Chengfu Yuan relative to Changgang Sun China Changgang Sun's profile →
Citations per field
00.5×7.4×
Changgang Sun · 1×
Citations per year

Countries citing papers authored by Chengfu Yuan

Since Specialization
Citations

This map shows the geographic impact of Chengfu Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfu Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfu Yuan more than expected).

Fields of papers citing papers by Chengfu Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengfu Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfu Yuan. The network helps show where Chengfu Yuan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chengfu Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chengfu Yuan Line = papers co-authored together Chengfu Yuan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20250
4 20240
5 20242
6 20241
7 20240
8 20243
9 20240
10 20241
11 20233
12 202118
13 20202
14 202014
15 201953
16 201820
17 201648
18 201429
19 201416
20
Melanoma differentiation-associated gene-7/interleukin 24 inhibits invasion and migration of human cervical cancer cells in vitro.
200713

About Chengfu Yuan

Chengfu Yuan is a scholar working on Cancer Research, Acoustics and Ultrasonics and Molecular Biology, having authored 114 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (53 papers), RNA modifications and cancer (40 papers), Circular RNAs in diseases (17 papers), RNA Research and Splicing (15 papers), Mycobacterium research and diagnosis (9 papers), MicroRNA in disease regulation (8 papers), Selenium in Biological Systems (5 papers) and Ginseng Biological Effects and Applications (5 papers). The work is most often cited by research in Cancer Research (778 citations), Molecular Biology (1.3k citations) and Oncology (457 citations). Chengfu Yuan has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Rex C. Haydon, Lei Yan, Hue H. Luu, Wenping Luo, Guosheng Ren, Bo Huang, Yixiao Feng, Linghuan Zhang, Xiaojuan Ji and Shifeng Huang. Their work appears in journals such as Journal of Biological Chemistry, Food Chemistry and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026